Papanas N - Search Results

1

Endothelial Dysfunction and Platelet Hyperaggregation in Type 2 Diabetes Mellitus: The Era of Novel Anti-diabetic Agents.

Daios S, Kaiafa G, Pilalas D, Nakou I, Kanellos I, Kirdas K, Despoudi K, Papanas N, Savopoulos C. Daios S, et al. Among authors: papanas n. Curr Med Chem. 2021;28(20):3935-3963. doi: 10.2174/0929867327666201009143816. Curr Med Chem. 2021. PMID: 33038906 Review.

2

Mean platelet volume in patients with type 2 diabetes mellitus.

Papanas N, Symeonidis G, Maltezos E, Mavridis G, Karavageli E, Vosnakidis T, Lakasas G. Papanas N, et al. Platelets. 2004 Dec;15(8):475-8. doi: 10.1080/0953710042000267707. Platelets. 2004. PMID: 15763888

3

Oral antidiabetic agents: anti-atherosclerotic properties beyond glucose lowering?

Papanas N, Maltezos E. Papanas N, et al. Curr Pharm Des. 2009;15(27):3179-92. doi: 10.2174/138161209789057995. Curr Pharm Des. 2009. PMID: 19754390 Review.

4

Breastfeeding and diabetes.

Gouveri E, Papanas N, Hatzitolios AI, Maltezos E. Gouveri E, et al. Among authors: papanas n. Curr Diabetes Rev. 2011 Mar;7(2):135-42. doi: 10.2174/157339911794940684. Curr Diabetes Rev. 2011. PMID: 21348815 Review.

5

Combination therapies of DPP4 inhibitors and GLP1 analogues with insulin in type 2 diabetic patients: a systematic review.

Rizos EC, Ntzani EE, Papanas N, Tsimihodimos V, Mitrogianni Z, Maltezos E, Elisaf MS. Rizos EC, et al. Among authors: papanas n. Curr Vasc Pharmacol. 2013 Nov;11(6):992-1000. doi: 10.2174/15701611113119990103. Curr Vasc Pharmacol. 2013. PMID: 22724475 Review.

6

Tofogliflozin: the road goes ever on.

Pafili K, Papanas N. Pafili K, et al. Among authors: papanas n. Expert Opin Pharmacother. 2014 Jun;15(9):1197-201. doi: 10.1517/14656566.2014.916278. Epub 2014 Apr 30. Expert Opin Pharmacother. 2014. PMID: 24787286

7

Gevokizumab in type 1 diabetes mellitus: extreme remedies for extreme diseases?

Pafili K, Papanas N, Maltezos E. Pafili K, et al. Among authors: papanas n. Expert Opin Investig Drugs. 2014 Sep;23(9):1277-84. doi: 10.1517/13543784.2014.947026. Epub 2014 Jul 31. Expert Opin Investig Drugs. 2014. PMID: 25079039 Review.

8

Effects of oral hypoglycemic agents on platelet function.

Papazafiropoulou A, Papanas N, Pappas S, Maltezos E, Mikhailidis DP. Papazafiropoulou A, et al. Among authors: papanas n. J Diabetes Complications. 2015 Aug;29(6):846-51. doi: 10.1016/j.jdiacomp.2015.04.005. Epub 2015 Apr 16. J Diabetes Complications. 2015. PMID: 26026848 Review.

9

Editorial: The New Trial EMPAREG-OUTCOMES in Type 2 Diabetes: "and Death Shall Have no Dominion"?

Papanas N, Tsioufis C, Maltezos ES. Papanas N, et al. Curr Vasc Pharmacol. 2016;14(4):316-8. doi: 10.2174/1570161114999160229142200. Curr Vasc Pharmacol. 2016. PMID: 26924324 No abstract available.

10

Prophylactic antibiotic treatment in severe acute ischemic stroke: the Antimicrobial chemopRrophylaxis for Ischemic STrokE In MaceDonIa-Thrace Study (ARISTEIDIS).

Tziomalos K, Ntaios G, Miyakis S, Papanas N, Xanthis A, Agapakis D, Milionis H, Savopoulos C, Maltezos E, Hatzitolios AI. Tziomalos K, et al. Among authors: papanas n. Intern Emerg Med. 2016 Oct;11(7):953-8. doi: 10.1007/s11739-016-1462-2. Epub 2016 May 23. Intern Emerg Med. 2016. PMID: 27216796

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

502 results

Search Page